Scott A Canute

Scott A Canute has an estimated net worth of $25.4 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, IMMUNOMEDICS INC, LILLY ELI & CO, Flexion Therapeutics Inc, Oncobiologics, Inc., PROTEON THERAPEUTICS INC, Akebia Therapeutics, Inc., and Oncorus, Inc..

2016 was Scott A Canute's most active year for acquiring shares with 9 total transactions. Scott A Canute's most active month to acquire stocks was the month of May. 2005 was Scott A Canute's most active year for disposing of shares, totalling 10 transactions. Scott A Canute's most active month to dispose stocks was the month of October. 2010 saw Scott A Canute paying a total of $5,063,480.00 for 117,750 shares, this is the most they've acquired in one year. In 2011 Scott A Canute cashed out on 142,750 shares for a total of $6,913,480.00, their largest year based on trade value.